Two Seas Capital
ABUS icon

Two Seas Capital’s Arbutus Biopharma ABUS Stock Holding History

Two Seas Capital’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$38.9M Sell
8,143,994
-10,951,589
-57% -$52.8M 0.45% 30
2026
Q2 		$91.7M Buy
19,095,583
+538,040
+3% +$2.36M 1.82% 14
2026
Q1 		$83.5M Buy
18,557,543
+5,968,385
+47% +$26.1M 1.17% 14
2025
Q4 		$60.6M Buy
12,589,158
+1,597,897
+15% +$7.19M 1.25% 14
2025
Q3 		$49.9M Buy
10,991,261
+547,944
+5% +$2.01M 0.8% 14
2025
Q2 		$32.3M Buy
10,443,317
+977,361
+10% +$3.25M 0.54% 17
2025
Q1 		$33M Buy
9,465,956
+725,000
+8% +$2.42M 1.04% 13
2024
Q4 		$28.6M Buy
8,740,956
+353,568
+4% +$1.3M 2.47% 13
2024
Q3 		$32.3M Sell
8,387,388
-184,363
-2% -$707K 5.23% 5
2024
Q2 		$26.5M Buy
8,571,751
+729,824
+9% +$2.19M 4.3% 7
2024
Q1 		$20.2M Sell
7,841,927
-1,200,000
-13% -$3.11M 3.96% 3
2023
Q4 		$22.6M Buy
9,041,927
+761,109
+9% +$1.49M 5.52% 4
2023
Q3 		$16.8M Hold
8,280,818
– – 3.38% 3
2023
Q2 		$19M Buy
8,280,818
+816,094
+11% +$2.12M 4.16% 3
2023
Q1 		$22.6M Sell
7,464,724
-39,469
-0.5% -$111K 20.76% 2
2022
Q4 		$17.5M Buy
7,504,193
+1,850,276
+33% +$4.43M 16.61% 2
2022
Q3 		$10.8M Buy
5,653,917
+2,152,041
+61% +$5.07M 9.86% 5
2022
Q2 		$9.49M Buy
3,501,876
+1,302,807
+59% +$3.33M 12.35% 4
2022
Q1 		$6.55M Buy
2,199,069
+1,373,500
+166% +$4.2M 5.49% 3
2021
Q4 		$3.21M Buy
+825,569
New +$3.21M 2.46% 4

Other funds holding ABUS

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return
Premier Path Wealth Partners
Premier Path Wealth Partners Madison, New Jersey $856M AUM 23.55% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Harbor Investment Advisory
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return
PWMG
Private Wealth Management Group Princeton, New Jersey $445M AUM 13.54% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Two Seas Capital's ABUS Position: Q3 2026 in Review

Two Seas Capital reduced its Arbutus Biopharma (ABUS) stake by 57% in Q3 2026, selling an estimated $52.8M and leaving 8,143,994 shares worth $38.9M. The position accounts for 0.45% of the portfolio, ranked #30.

Two Seas Capital first reported a position in ABUS in Q4 2021 and has held it in 20 quarters since. The position peaked at $91.7M in Q2 2026. 12 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • Two Seas Capital held 8,143,994 shares of Arbutus Biopharma worth $38.9M as of Q3 2026.
  • Two Seas Capital sold 10,951,589 Arbutus Biopharma shares in Q3 2026, an estimated $52.8M.
  • Arbutus Biopharma made up 0.45% of Two Seas Capital's portfolio in Q3 2026, its #30 holding.
  • Two Seas Capital first reported a position in Arbutus Biopharma in Q4 2021 and has held it in 20 quarters since.
  • Two Seas Capital's Arbutus Biopharma position peaked at $91.7M in Q2 2026.
  • 12 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on Two Seas Capital's 13F filing for Q3 2026, filed 6 Oct 2026.